JPRN-UMIN000029742
Recruiting
未知
Validation of novel biomarkers for treatment response to rush oral immunotherapy for food allergy in children - Immunoglobulin Maturation and Affinity Kinetics in Immunotherapy for Food Allergy (IMAKIFA) Study
Department of Clinical Research, Mie National Hospital0 sites30 target enrollmentOctober 28, 2017
ConditionsFood allergy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Food allergy
- Sponsor
- Department of Clinical Research, Mie National Hospital
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.patients with any chronic disease other than allergic diseases 2\.patients with uncontrolled asthma or atopic dermatitis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Clinical evaluation of new biomarkers in diagnosis of valproate-induced renal tubular dysfunction.EpilepsyJPRN-UMIN000015787Department of Pediatrics, Kansai medical university100
Not yet recruiting
Not Applicable
To calculate new biomarkers and its efficacy of the progresion for non-alcoholic fatty liver disease patients.non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000014550Shinshu University of Medicine600
Recruiting
Not Applicable
Preliminary study for evaluating novel biomarker in the pathogenesis of breast cancerBreast cancerJPRN-UMIN000047529Kobe City Medical Center General Hospital60
Completed
Not Applicable
Prospective evaluation of the novel biomarkers penKid, bio-arm and DPP3 in the early the detection of complications following major hepatic resectionshemihepatectomyALPPS-proceduremajor liver resection >2 segmentsDRKS00028568niverstitätsklinikum Hamburg-Eppendorf24
Completed
Not Applicable
Research for new biomarker about diagnosis and evaluation of disease condition for inflammatory bowel disease (IBD).Inflammatory bowel diseaseJPRN-UMIN000017831Kyoto Prefectural University of Medicine400